AFP
|
Liver, germ cell cancer of ovaries or testes |
Also elevated during pregnancy and in hepatitis |
Help diagnose, monitor treatment, and determine recurrence |
Blood |
| CA 15-3 |
Breast and others including lung, ovarian |
Also elevated in benign breast conditions. |
Stage disease, monitor treatment, and determine recurrence |
Blood |
| CA 19-9 |
Pancreatic, sometimes bowel and bile ducts |
Also elevated in pancreatitis and inflammatory bowel disease |
Stage disease, monitor treatment, and determine recurrence |
Blood |
| CA-125 |
Ovarian |
Also elevated with endometriosis, some other diseases and benign conditions; not recommended as a general screen |
Stage disease, monitor treatment, and determine recurrence |
Blood |
| CEA |
Bowel, lung, breast, thyroid, pancreatic, liver, cervix, and bladder |
Elevated in other conditions such as hepatitis, COPD, colitis, pancreatitis, and in cigarette smokers |
Monitor treatment and determine recurrence |
Blood |
| Oestrogen receptors |
Breast |
Increased in hormone- dependent cancer |
Determine prognosis and guide treatment |
Tissue |
| hCG |
Testicular and trophoblastic |
Elevated in pregnancy, testicular failure |
Help diagnose, monitor treatment, and determine recurrence |
Blood, urine |
| Her-2/neu |
Breast |
that is present in multiple copies in 20-30% of invasive breast cancer |
Determine prognosis and guide treatment |
Tissue |
| Monoclonal immunoglobulins |
Multiple myeloma and Waldenstrom’s macroglobulinemia |
Overproduction of an immunoglobulin or antibody, usually detected by protein electrophoresis |
Help diagnose, monitor treatment, and determine recurrence |
Blood, urine |
| Progesterone receptors |
Breast |
Increased in hormone-dependent cancer |
Determine prognosis and guide treatment |
Tissue |
| PSA |
Prostate |
Elevated in benign prostatic hypertrophy, prostatitis and with age |
Help diagnose, monitor treatment, and determine recurrence |
Blood |